Vaccination
The AIDS Healthcare Foundation (AHF), the world's largest AIDS group, has welcomed news that the US will have 3 million vaccine doses per day available by April. The organization has expressed enthusiasm about the scaled-up production numbers for COVID-19 vaccines presented by vaccine makers at the US House
Vaccines
Montenegro's efforts to combat the COVID-19 pandemic are hampered by delays in the procurement process and widespread scepticism about the safety of coronavirus vaccines. The country is expecting to receive its first doses of the vaccine from the COVAX scheme in the first quarter of 2021, but has
COVID-19 vaccines
As the world continues to fight against the COVID-19 pandemic, young volunteers are stepping up to participate in a vaccine trial to help bring an end to the outbreak. Children as young as six are taking part in a new study to test the effectiveness of the Oxford/AstraZeneca vaccine
Vaccines
As school districts across the United States face the challenge of reopening safely, clinical trials to test COVID-19 vaccines on children are gaining momentum. The University of Oxford and AstraZeneca are the latest vaccine developers to detail their plans to study the safety and effectiveness of their vaccine in children.
COVID-19 vaccines
The World Health Organization (WHO) has granted an Emergency Use Listing (EUL) to the Oxford/AstraZeneca vaccine for the prevention of COVID-19 in individuals 18 years of age and older, including those over 65. This milestone paves the way for global access to the vaccine, particularly in low- and middle-income
Pharmaceutical industry
Cleveland, Ohio, researchers have investigated the efficacy of ipilimumab plus nivolumab in patients with metastatic non-clear cell renal cell carcinoma, a type of kidney cancer. According to a study published in Clinical Genitourinary Cancer, the combination of these two immunotherapies demonstrated objective responses and notable toxicity in patients with this
Pharmaceutical industry
South Korea is on track to receive new coronavirus vaccines from American pharmaceutical company Pfizer between late February and early March, with initial inoculations using AstraZeneca vaccines produced in South Korea to begin in late February. The government plans to begin COVID-19 vaccinations later this month, with front-line medical workers
COVID-19
The VEGF inhibitor market is experiencing a decline due to the COVID-19 pandemic, but it is expected to recover and grow significantly in the coming years. The market was valued at $0.31 billion in 2019 and is projected to reach $1.72 billion by 2023 at a compound annual
COVID-19
South Africa is racing to adjust its COVID-19 vaccination strategy after preliminary data suggested the AstraZeneca vaccine may be only minimally effective against the country's dominant variant, prompting the suspension of its use among health workers. The country is now weighing the option of giving Johnson & Johnson&
Vaccines
Big pharmaceutical companies are opposing temporary suspensions of patents on COVID-19 vaccines and drugs, claiming that intellectual property rights are essential for innovations. However, developing countries are struggling to access affordable vaccines and drugs. The World Health Organization's patent pooling initiative, Covid-19 Technology Access Pool (C-TAP), has been
Vaccination
A government-backed study has been launched in the UK to determine whether using different coronavirus vaccines for the first and second doses is safe and effective. The programme, dubbed Com-Cov, has received £7 million in funding from the government's Vaccine Taskforce and aims to establish whether a mixed-dose
Vaccines
Ursula von der Leyen, the European Commission president, has announced that she secured assurances from Boris Johnson that the EU would receive vaccine supplies from AstraZeneca factories in Britain. The agreement comes amidst a bitter row between the EU and AstraZeneca over vaccine delivery schedules. According to von der Leyen,
